NP Medical News about Influenza A Virus, H1N1 Subtype Influenza Vaccines

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09

Mitchell D – The first wave of vaccine against the novel influenza A (H1N1) virus is expected to be delivered to vaccinators beginning the week of Oct. 5–9. 25 state and local public health agencies placed initial orders for 600,000 doses of the vaccine as of Sept. 30. The agency plans to give weekly updates on the amount of vaccine available for ordering and how much is shipped to each state or large city. Those updates are to be given every Friday. The early shipments of H1N1 vaccine will be the nasal spray formulation, which is the live, attenuated influenza vaccine, or LAIV. That vaccine can be given to healthy, nonpregnant individuals ages 2–49 years. The CDC announced in August that it had expanded its partnership with McKesson Corp. to include centralized distribution of the H1N1 flu vaccine. Physicians interested in providing the H1N1 vaccine should contact their state immunization program administrators because state agencies are determining who will participate in the initiative.

<< Previous
CCHIT Revamping EHR Certification

Next >>
Emerging Risk Factors for Coronary Heart Disease: A Summary of...

Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09 Relevance Score: 99%

H1N1 vaccine shortage leaves doctors managing crowds, anxieties
American Medical News, 11/06/09 Relevance Score: 98%

H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09 Relevance Score: 98%

Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009
Annals of Internal Medicine, 10/09/09 Relevance Score: 98%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09 Relevance Score: 98%